BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30194082)

  • 21. Upregulated LMO1 in prostate cancer acts as a novel coactivator of the androgen receptor.
    Gu H; Liu T; Cai X; Tong Y; Li Y; Wang C; Li F
    Int J Oncol; 2015 Dec; 47(6):2181-7. PubMed ID: 26459575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68.
    Zhao D; Tian Y; Li P; Wang L; Xiao A; Zhang M; Shi T
    Mol Med Rep; 2015 Oct; 12(4):5554-60. PubMed ID: 26136151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
    Bui CB; Le HK; Vu DM; Truong KD; Nguyen NM; Ho MAN; Truong DQ
    Mol Carcinog; 2019 Nov; 58(11):1998-2007. PubMed ID: 31365169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.
    Xue C; Yu DM; Gherardi S; Koach J; Milazzo G; Gamble L; Liu B; Valli E; Russell AJ; London WB; Liu T; Cheung BB; Marshall GM; Perini G; Haber M; Norris MD
    Oncotarget; 2016 Aug; 7(34):54937-54951. PubMed ID: 27448979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
    Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
    J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells.
    Bachetti T; Di Zanni E; Ravazzolo R; Ceccherini I
    Biochim Biophys Acta; 2015 Aug; 1849(8):1057-65. PubMed ID: 26145533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
    Tse E; Smith AJ; Hunt S; Lavenir I; Forster A; Warren AJ; Grutz G; Foroni L; Carlton MB; Colledge WH; Boehm T; Rabbitts TH
    Mol Cell Biol; 2004 Mar; 24(5):2063-73. PubMed ID: 14966285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The highly related LIM factors, LMO1, LMO3 and LMO4, play different roles in the regulation of the pituitary glycoprotein hormone alpha-subunit (alpha GSU) gene.
    Susa T; Ishikawa A; Cai LY; Kato T; Matsumoto K; Kitahara K; Kurokawa R; Ono T; Kato Y
    Biosci Rep; 2009 Oct; 30(1):51-8. PubMed ID: 19228115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
    Wang Z; Lei H; Sun Q
    Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10.
    Wang X; Li J; Xu X; Zheng J; Li Q
    Biomed Pharmacother; 2018 Jul; 103():1312-1318. PubMed ID: 29864913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angelica sinensis polysaccharide inhibits proliferation, migration, and invasion by downregulating microRNA-675 in human neuroblastoma cell line SH-SY5Y.
    Yang J; Shao X; Jiang J; Sun Y; Wang L; Sun L
    Cell Biol Int; 2018 Jul; 42(7):867-876. PubMed ID: 29465760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
    Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
    RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.
    Aoyama M; Ozaki T; Inuzuka H; Tomotsune D; Hirato J; Okamoto Y; Tokita H; Ohira M; Nakagawara A
    Cancer Res; 2005 Jun; 65(11):4587-97. PubMed ID: 15930276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.
    Hsu CL; Chang HY; Chang JY; Hsu WM; Huang HC; Juan HF
    Oncotarget; 2016 Jun; 7(24):36293-36310. PubMed ID: 27167114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocyte Chemoattractant Protein-Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells.
    Boratyn E; Nowak I; Horwacik I; Durbas M; Mistarz A; Kukla M; Kaczówka P; Łastowska M; Jura J; Rokita H
    J Cell Biochem; 2016 Mar; 117(3):694-707. PubMed ID: 26308737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma.
    Scaruffi P; Stigliani S; Moretti S; Coco S; De Vecchi C; Valdora F; Garaventa A; Bonassi S; Tonini GP
    BMC Cancer; 2009 Dec; 9():441. PubMed ID: 20003513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.